HealthTech
Microfluidics has been a rapidly growing field within a range of engineering disciplines over the past few decades, with applications running from thermal control...
Hi, what are you looking for?
IoT is transforming healthcare through wearables, SaMD, and AI. MedTech needs strong branding for the efficiency and cost savings this will provide.
The lack of standardization is a huge problem in the diagnosis and tracking of neurological disorders: because they are so complex and often slow...
System creates 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize therapeutic interventions
Linear Health Sciences has received U.S. FDA clearance and Health Canada approval of its Orchid SRV, a tension-activated breakaway safety release valve designed to reduce the...
Microfluidics has been a rapidly growing field within a range of engineering disciplines over the past few decades, with applications running from thermal control...
The Alleviant System is a transcatheter technology intended to reduce pressure within the left atrium through the creation of a therapeutic interatrial shunt without...
The platform can be used for medical education, patient care, and management. In addition, pharma companies can use it to create models for drug...
Combinostics, a neurology technology company looking at everything from early detection and diagnosis to the ongoing management of neurological disorders, has announced the Dementia...
Medtech start-up company VisusNano has been awarded £1.39 million in non-dilutive funding from the Innovate UK Biomedical Catalyst programme to further develop MEDILens, a drug-eluting IOL,...
Biosensors International has announced both the Japanese PMDA Approval for BioFreedom Ultra and US FDA Approval for BioFreedom.
Biostage Announces $5.1 Million Financing To Advance Clinical Trial Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted...
Foldax is trying to eliminate the tradeoff between mechanical and tissue heart valves by starting from scratch.
The Dublin, Ireland-based device maker has the first system cleared by the FDA that uses artificial intelligence to detect potential signs of colon cancer....
Time to diagnosis can be more than three years, with one study estimating at least half of IPF patients are misdiagnosed once or more.